Singapore announces precision oncology partnership
Singapore announces precision oncology partnership 10 February 2021 | News Public sector partners will provide research expertise and insights to build infrastructure for data sharing, and Roche will provide access to genomic testing and guidance on infrastructure design and implementation
Photo Credit: Roche Singapore
Singapore Translational Cancer Consortium (STCC), National Cancer Centre Singapore (NCCS), the National University Cancer Institute, Singapore (NCIS) at the National University Hospital (NUH) and Roche announced a unique and groundbreaking partnership between public and private sector institutions in Singapore aimed at establishing a critical infrastructure to advance the adoption of personalised healthcare in Singapore. Personalised healthcare, which includes precision oncology or personalised cancer care, leverages insights from medical and genomic data to help make more precise treatment decisions